The clinicopathological significance of IL-8/integrin β3 expression was evaluated by comparing the IL-8/integrin β3 positive group with the IL-8/integrin β3 negative group of patients with HCC (Table 1). The gene discussed is CXCL8; the disease is hepatocellular carcinoma.